NAD+ · Cellular coenzyme research context

Nicotinamide adenine dinucleotide, commonly written as NAD+, is a coenzyme found in every living cell. It is not a peptide; it is a small molecule built from two nucleotides joined through their phosphate groups. Researchers describe it as central to cellular metabolism because it participates in the chemical reactions that convert nutrients into usable energy.

In the scientific literature NAD+ is discussed in two broad roles: as a carrier of electrons during metabolism, cycling between its oxidized form (NAD+) and its reduced form (NADH), and as a substrate that is consumed by certain enzyme families. Because it is a naturally occurring cofactor rather than a synthetic drug, discussion of NAD+ in research settings focuses on its biochemistry rather than any specific therapeutic outcome.

This page is educational only. It does not describe dosing, does not make treatment claims, and does not suggest that NAD+ is appropriate for any individual. A licensed provider determines appropriateness for any person after a confidential intake.

Mechanistically, NAD+ is studied as an electron carrier in the pathways that break down carbohydrates, fats, and proteins. During these reactions it accepts electrons to become NADH, which then feeds those electrons into the mitochondrial machinery associated with cellular energy production.

Beyond its role in energy metabolism, NAD+ is described in the literature as a substrate for enzyme families such as the sirtuins and PARPs, which are studied in the context of DNA repair signaling and the regulation of cellular processes. Because these enzymes consume NAD+, researchers examine how cellular pools of the coenzyme are maintained and recycled.

How any of this translates to human health is an area of ongoing investigation. Statements here describe pathways reported in laboratory and preclinical research, not established clinical effects. Any application to a specific person is a clinical decision made by a qualified provider.

Regulatory status varies by country and can change. NAD+ and its precursors appear in different regulatory categories depending on jurisdiction and formulation, and nothing on this page should be read as a statement that any particular product is approved or appropriate for a given use.

This material is provided for education only. It is not medical advice, and it does not establish a provider–patient relationship. A licensed provider reviews each person's history and determines appropriateness after a confidential intake.

Education only · provider review required.